APA (7th ed.) Citation

Nardone, V., Patanè, V., Marinelli, L., D'Ambrosio, L., Del Tufo, S., De Chiara, M., . . . Reginelli, A. (2025). Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial). Diagnostics (2075-4418), 15(22), 2914. https://doi.org/10.3390/diagnostics15222914

Chicago Style (17th ed.) Citation

Nardone, Valerio, et al. "Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial)." Diagnostics (2075-4418) 15, no. 22 (2025): 2914. https://doi.org/10.3390/diagnostics15222914.

MLA (9th ed.) Citation

Nardone, Valerio, et al. "Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial)." Diagnostics (2075-4418), vol. 15, no. 22, 2025, p. 2914, https://doi.org/10.3390/diagnostics15222914.